Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Macular edema in the study eye due to RVO or DME
Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on or after August 2012 for DME
You may not be if
None
Clareo Health | A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
